In one sentence
A careful review of 16 studies suggests that autistic children tend to have higher levels of certain gut bacteria byproducts (short-chain fatty acids) — specifically valeric, hexanoic, and isobutyric acids — compared with non-autistic children.
What the researchers did
Researchers asked whether levels of short-chain fatty acids (SCFAs) — molecules made when gut bacteria break down food — differ between autistic people and non-autistic controls. They searched five major medical databases through December 2024 and included 16 observational studies that measured SCFAs in stool, blood, or urine. Together those studies covered 473 autistic individuals and 514 controls. Results were pooled with a random-effects meta-analysis so overall patterns could be seen across studies.
What they found
- Valeric acid was higher in autistic individuals (standardised mean difference 0.76, 95% CI 0.23–1.29).
- Hexanoic acid was also higher (SMD 0.60, 95% CI 0.05–1.16).
- Isobutyric acid showed a smaller but more consistent increase (SMD 0.21, 95% CI 0.03–0.46).
- Acetic, propionic, and butyric acids showed no overall group difference, though results varied by sample type (stool, blood, or urine).
- Heterogeneity across studies was substantial for most SCFAs, so findings were not uniform.
What this means for families and therapists
- This adds to evidence that gut microbes and their byproducts may differ in autism, but it does not prove cause and effect. It is too early to recommend diets or supplements based on these results alone.
- Routine SCFA testing is not yet clinically useful for autism assessment or treatment planning.
- If gut health is a concern, talk with a clinician who knows autism well, and ask what — if anything — current evidence supports for your child’s situation.
Limitations and what we don't know yet
- All included studies were observational, so they cannot show that SCFAs cause autism or its symptoms.
- High between-study heterogeneity likely reflects different sample types, lab methods, and participant groups.
- The evidence base is still modest (16 studies, about 987 people total).
- Most studies were cross-sectional snapshots, so we do not know how SCFA levels change over time.
- Diet, medication, and other lifestyle factors were often poorly accounted for.
This is a plain-language summary of Autism and the gut metabolome: Evidence for altered short-chain fatty acid profiles from a systematic review and meta-analysis by Yang Z, Chen X, Li Y et al., Brain, behavior, & immunity - health (2026). Source license: CC-BY-NC-ND. It is not medical advice — talk to a qualified clinician before changing therapy.